On (b)(6) 2019, an eye care provider (ecp) from (b)(6) reported that a patient (pt) experienced discomfort after insertion of 1-day acuvue® define¿ with lacreon® brand contact lenses (cl).On (b)(6) 2019, additional information was received from the pt: the pt reported experiencing discomfort in the right eye (od) after a few hours of cl wear on (b)(6) 2019.The pt still felt discomfort od after removal of the cl.The pt visited an ophthalmologist on (b)(6) 2019 and was diagnosed with keratitis.Two eye drops were prescribed: ganciclovir eye drops and levofloxacin hydrochloride eye drops, once every 2 hours.The pt is currently experiencing itchiness and still being able to ¿feel something¿ in the od.The pt was not able to provide a medical report.On (b)(6) 2019, additional information was received from the pt: the pt reported the od was better but still dry.The pt did not return to see the ophthalmologist.The pt is currently still using the same previously prescribed eye drops.No additional information has been received.The suspect cl is not available for return.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot 3332160104 was produced under normal conditions.If any further relevant information is received, a supplemental report will be filed.
|